amantadine has been researched along with modafinil in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Christodoulou, C; Krupp, LB | 1 |
| Zifko, UA | 1 |
| Murray, TJ; Schwid, SR | 1 |
| Debouverie, M; Pittion, S | 1 |
| Boërio, D; Créange, A; Hogrel, JY; Lefaucheur, JP | 1 |
| Antigüedad, AR; Benito-León, J; de Andrés, C; Frades, B; Huete-Antón, B; Martínez-Ginés, ML; Martínez-Martín, P; Meca-Lallana, JE; Rodríguez-García, E; Ruiz-Martínez, J | 1 |
| Elsner, F; Krumm, N; Peuckmann, V; Radbruch, L; Trottenberg, P | 1 |
| Kirshbaum, M | 1 |
| Constantinescu, CS; Gran, B; Induruwa, I | 1 |
| Ledinek, AH; Rot, U; Sajko, MC | 1 |
| Cuhls, H; Minton, O; Mücke, M; Peuckmann-Post, V; Radbruch, L; Stone, P | 1 |
| Nourbakhsh, B; Revirajan, N; Waubant, E | 1 |
| Brown, CS; Cote, J; Eldridge, A; Gagnon, DJ; Leclerc, AM; May, T; Nocella, K; Riker, RR; Seder, DB | 2 |
| Aljarallah, S; Auvray, C; Cordano, C; Creasman, J; Jin, C; Krysko, K; Manguinao, M; McCulloch, C; Morris, B; Mowry, E; Nourbakhsh, B; Revirajan, N; Rutatangwa, A; Waubant, E | 1 |
| Bourdette, D | 1 |
9 review(s) available for amantadine and modafinil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fatigue in multiple sclerosis.
Topics: Amantadine; Autoimmune Diseases; Benzhydryl Compounds; Brain; Case Management; Central Nervous System Stimulants; Combined Modality Therapy; Cross-Over Studies; Depression; Double-Blind Method; Fatigue; Hot Temperature; Humans; Hypothalamus; Methylphenidate; Modafinil; Multiple Sclerosis; Patient Care Team; Pemoline; Physical Therapy Modalities; Pilot Projects; Randomized Controlled Trials as Topic; Self-Assessment; Severity of Illness Index; Tomography, Emission-Computed | 2001 |
Management of fatigue in patients with multiple sclerosis.
Topics: Amantadine; Antidepressive Agents; Benzhydryl Compounds; Central Nervous System Stimulants; Clinical Trials as Topic; Dopamine Agents; Electromagnetic Fields; Exercise; Fatigue; Humans; Modafinil; Multiple Sclerosis | 2004 |
[Pathophysiology and treatment of fatigue in multiple sclerosis].
Topics: 4-Aminopyridine; Acute Disease; Amantadine; Amifampridine; Asthenia; Benzhydryl Compounds; Central Nervous System; Chronic Disease; Fatigue; Humans; Mental Fatigue; Modafinil; Multiple Sclerosis; Pemoline; Peripheral Nervous System; Physical Exertion; Severity of Illness Index; Surveys and Questionnaires | 2006 |
Pharmacological treatments for fatigue associated with palliative care.
Topics: Adult; Amantadine; Benzhydryl Compounds; Central Nervous System Stimulants; Fatigue; Humans; Kidney Failure, Chronic; Methylphenidate; Modafinil; Multiple Sclerosis; Neoplasms; Palliative Care; Pemoline; Randomized Controlled Trials as Topic | 2010 |
Pharmacologic treatments for fatigue associated with palliative care.
Topics: Amantadine; Benzhydryl Compounds; Central Nervous System Stimulants; Evidence-Based Medicine; Fatigue; Humans; Modafinil; Palliative Care; Pemoline; Randomized Controlled Trials as Topic | 2011 |
Fatigue in multiple sclerosis - a brief review.
Topics: Amantadine; Atrophy; Benzhydryl Compounds; Brain; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cytokines; Depression; Diffuse Axonal Injury; Double-Blind Method; Exercise Therapy; Fatigue; Humans; Hypothalamo-Hypophyseal System; Immunologic Factors; Modafinil; Multiple Sclerosis; Pemoline; Pituitary-Adrenal System; Quality of Life; Single-Blind Method; Sleep Disorders, Intrinsic | 2012 |
Pharmacological treatments for fatigue associated with palliative care.
Topics: Adult; Amantadine; Benzhydryl Compounds; Carnitine; Central Nervous System Stimulants; Chronic Disease; Fatigue; Humans; Kidney Failure, Chronic; Methylphenidate; Modafinil; Multiple Sclerosis; Neoplasms; Palliative Care; Pemoline; Randomized Controlled Trials as Topic | 2015 |
Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic Review.
Topics: Amantadine; Central Nervous System Stimulants; Dopamine Agents; Humans; Modafinil; Recovery of Function; Stroke | 2020 |
3 trial(s) available for amantadine and modafinil
| Article | Year |
|---|---|
Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study.
Topics: Acetylcarnitine; Adult; Amantadine; Benzhydryl Compounds; Drug Combinations; Fatigue; Female; Humans; Male; Middle Aged; Modafinil; Multiple Sclerosis; Pilot Projects; Treatment Outcome | 2013 |
Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
Topics: Amantadine; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Fatigue; Humans; Methylphenidate; Modafinil; Multiple Sclerosis; Research Design | 2018 |
Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
Topics: Adult; Amantadine; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Fatigue; Female; Humans; Male; Methylphenidate; Middle Aged; Modafinil; Multiple Sclerosis; Outcome Assessment, Health Care; Severity of Illness Index | 2021 |
7 other study(ies) available for amantadine and modafinil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Treating fatigue in patients with MS: one step forward, one step back.
Topics: Amantadine; Aspirin; Benzhydryl Compounds; Central Nervous System; Central Nervous System Stimulants; Cross-Over Studies; Dopamine Agents; Fatigue; Humans; Modafinil; Multiple Sclerosis; Pemoline; Randomized Controlled Trials as Topic; Treatment Outcome | 2005 |
[Fatigue and episodic exhaustion as a feature of multiple sclerosis].
Topics: 4-Aminopyridine; Amantadine; Amifampridine; Benzhydryl Compounds; Fatigue; Humans; Hypnotics and Sedatives; Modafinil; Multiple Sclerosis; Severity of Illness Index; Surveys and Questionnaires | 2006 |
Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS).
Topics: Adolescent; Adult; Aged; Amantadine; Benzhydryl Compounds; Central Nervous System Stimulants; Dopamine Agents; Fatigue; Female; Humans; Male; Middle Aged; Modafinil; Multiple Sclerosis; Psychometrics; Quality of Life | 2007 |
Amantadine and Modafinil as Neurostimulants Following Acute Stroke: A Retrospective Study of Intensive Care Unit Patients.
Topics: Adult; Amantadine; Central Nervous System Stimulants; Humans; Intensive Care Units; Modafinil; Retrospective Studies; Stroke | 2021 |
Are drugs for multiple sclerosis fatigue just placebos?
Topics: Amantadine; Double-Blind Method; Fatigue; Humans; Methylphenidate; Modafinil; Multiple Sclerosis; Pharmaceutical Preparations | 2021 |